M. Douglas Winship - VP, Catalyst Pharmaceuticals, Inc

As of November 5, 2015


M. Douglas Winship Net Worth

  • Net worth is estimated to be at least $793.75K
  • Owns at least 74,131 units of Catalyst Pharmaceuticals, Inc stock
  • Sold an estimated value of $141.55K in the last 7 years at Catalyst Pharmaceuticals, Inc

M. Douglas Winship Compensation at Catalyst Pharmaceuticals, Inc in 2018

  • Earned a $399,373 salary and a $194 bonus
  • Rewarded $ in stock value and options
  • Received a total compensation of $

M. Douglas Winship Trading

  • Largest purchase of shares was 12,500 units , worth over $10K on May 29, 2012
  • Largest sale of shares was 22,800 units , worth over $76.15K on October 23, 2015
  • In total has made about 12 transactions over 7 years
  • Usually trades in October, with the busiest year in 2009
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

M. Douglas Winship Mailing Address

  • Mailing address is 220 Miracle Mile Suite 234 Coral Gables FL 33134 FL

Catalyst Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Other Earnings Plans or Compensations
Patrick J. McEnany 2018 $524,236 $332,063 $ $3,461,504 $3,461,504 $ $3,461,504
Steven R. Miller, COO and CSO 2018 $427,441409,325 $188,600 $ $1,655,195 $1,655,195 $11,000 $1,655,195
Gary Ingenito, CM&RO 2018 $399,373 $194,810 $ $1,666,645 $1,666,645 $26,192 $1,666,645
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1369568/000119312520188818/d932120ddef14a.htm

Catalyst Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 80,000 units sold on August 26, 2021 by Steve Miller worth over $444.64K
  • In the last 14 years, insiders at Catalyst Pharmaceuticals, Inc sold an estimated value of $5.01M and bought an estimated value of $11.77M
  • The most active traders are Patrick J McEnany, President and CEO,  Charles B. O'Keeffe, Director,  and Philip H Coelho, Director
  • Insider trading is most common in December, with the busiest year in 2008

CATALYST PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1